Cas:495414-58-9 4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid manufacturer & supplier

Chemical Name:4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid

CAS.NO:495414-58-9

Synonyms:4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid

Molecular Formula:C₁₄H₂₃NO₄

Molecular Weight:269.33700

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:66.84000

Exact Mass:269.16300

LogP:2.60230

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid Use and application,4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid technical grade,usp/ep/jp grade.

Related News: Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important. 4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid manufacturer Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid supplier An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid vendor Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important. 4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid factory Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.